Riboflavin topical - Avedro

Drug Profile

Riboflavin topical - Avedro

Alternative Names: KXL; KXL System®; ParaCel; Photrexa; Photrexa Viscous; Riboflavin ophthalmic solution; Riboflavin ophthalmic solution/KXL system; VibeX; VibeX Rapid; VibeX Xtra

Latest Information Update: 04 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Avedro
  • Class Antimigraines; Flavins; Small molecules; Vitamins
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Corneal injuries; Keratoconus
  • New Molecular Entity No

Highest Development Phases

  • Marketed Corneal injuries; Keratoconus

Most Recent Events

  • 28 Sep 2016 Launched for Corneal injuries in USA (Topical)
  • 28 Sep 2016 Launched for Keratoconus in USA (Topical)
  • 19 Jul 2016 Efficacy data from a phase II and phase III trials in Keratoconus released by Avedro
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top